Related Experiment Videos
Endotoxin-induced enteric hypomotility in jaundiced loops in vitro
I Duval-Araujo1, A Petroianu, J E Oliveira-Neto
1Departamento de Cirurgia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Horizonte, Brasil.
Summary
Biliary obstruction and endotoxemia significantly impair intestinal motility in rats. This study shows endotoxin addition further reduces ileal motor response, highlighting a critical link between gut bacteria and digestive function during jaundice.
Area of Science:
- Gastroenterology
- Physiology
- Endocrinology
Background:
- Biliary obstruction can lead to systemic endotoxemia due to altered gut microbiota and impaired liver function.
- Endotoxemia is associated with increased postoperative complications and mortality.
- Previous research indicates intestinal hypomotility in jaundiced conditions.
Purpose of the Study:
- To investigate the impact of jaundice and endotoxemia on ileal motor response in rats.
- To determine how intraluminal endotoxin affects the contractility of jaundiced rat ileum.
Main Methods:
- In vitro study using isolated ileal segments from jaundiced Holtzman rats.
- Rats were divided into two groups: jaundiced and jaundiced with added endotoxin.
- Dose-response curves to acetylcholine were assessed in an organ chamber to measure motor response.
Main Results:
- Intraluminal endotoxin significantly increased the threshold dose for acetylcholine-induced contraction in jaundiced ileal segments (291 ± 188 vs 8.5 ± 6.7 μM, P < 0.05).
- The maximum contraction was reduced in jaundiced loops with endotoxin compared to controls (5.3 ± 1.7 vs 18.7 ± 4.8 mm, P < 0.05).
- pD2 values were also significantly lower in the endotoxin-treated jaundiced group (2.4 ± 0.6 vs 3.7 ± 0.5, P < 0.05).
Conclusions:
- Intraluminal endotoxin significantly depresses enteric motility in jaundiced rats.
- This finding suggests a mechanism contributing to gastrointestinal dysfunction during biliary obstruction and endotoxemia.
- Further research is warranted to explore therapeutic strategies targeting gut microbiota and endotoxin levels.